WHO ATC level 1 category | Local generics | Imported generics | Originator |
---|---|---|---|
All products | 1.45 (0.94–2.57) | 2.14 (1.07–4.34) | 4.04 (1.50–6.88) |
A – Alimentary tract and metabolism | 1.44 (1.18–2.57) | 2.09 (1.24–4.71) | 1.52 (0.97–4.39) |
B – Blood and blood forming organs | 1.95 (1.59–16.78) | 4.89 (2.80–8.19) | 3.20 (2.25–3.27) |
C – Cardiovascular system | 1.42 (0.81–2.09) | 3.09 (1.00–4.37) | 7.43 (4.60–14.59) |
D – Dermatalogicals | 1.00 (0.44–1.50) | 1.46 (1.12–1.70) | 1.08 (0.36–1.80) |
G – Genito-urinary system and sex hormones | 0.42 (0.39–0.52) | 1.16 (0.56–2.84) | 4.59 (3.12–6.43) |
H - Systemic hormonal preparations, excluding sex hormones and insulins | 1.70 (1.06–2.13) | 0.82 (0.58–1.33) | 0.52 (0.23–0.91) |
J – Anti-infectives for systemic use | 1.80 (1.24–4.33) | 2.74 (1.60–5.00) | 4.45 (1.92–7.79) |
L – Antineoplastic agents and immunomodulating agents | – | 1.28 (0.46–2.55) | 1.73 (1.70–2.13) |
M – Musculo-skeletal system | 1.11 (0.45–1.88) | 4.28 (2.72–6.77) | 5.13 (1.42–8.74) |
N – Nervous system | 1.17 (0.66–2.69) | 2.24 (1.57–6.21) | 4.35 (1.03–5.19) |
P – Antiparasitic products, insecticides and repellents | 1.79 (1.28–2.00) | 3.14 | – |
R – Respiratory system | 2.13 (0.62–3.57) | 1.75 (1.06–4.25) | – |
S – Sensory organs | 1.13 (0.82–1.32) | 2.36 (1.42–3.46) | 0.65 (0.22–5.57) |